In more recent studies - we have seen positive research using the Kazia drug paxalisib in somewhat rare CNS disease.
But investors will love reading this information, from a top 10 medical research university in the UK......released on the web, a few hours ago..... from the Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London.
It is very deep research, which you will note.
Quote here from this London Royal Holloway University - which highlights just absolute stunning new information, as to the potential of paxalisib.
Inactivation of mTORC1 through combinatory treatment with Paxalisib and T2A may provide a useful approach in treating other diseases arising from PI3K/PKB/mTORC1 dysregulation. These diseases include many cancer types such as blader [68], ovarian [69], breast [70, 71] and non-small cell lung cancers [72] as well as inflammatory diseases like restenosis and neointimal hyperplasia [73]. It may also provide novel approaches in the treatment of a variety of neurological diseases such as epilepsy [74,75,76], and autism spectrum disorder [77] and metabolic disorders including Type II Diabetes Mellitus [78]. Thus, using PI3K inhibitors and T2A in combination may be beneficial to the treatment of a range of diseases.
-------------------------------------------------------------------
It is fair to scrutinize, exactly who produced this highly detailed study. So more below on the Royal Holloway University, London.
From Wikipedia, the free encyclopedia
Column 1
Column 2
Column 3
Column 4
Column 5
Column 6
Column 7
Column 8
Column 9
Column 10
Column 11
Column 12
Column 13
Column 14
Column 15
Column 16
Column 17
0
{caption}Royal Holloway, University of London{/caption}
1849: Bedford College1879: Royal Holloway College1900: became a constituent college of the University of London1985: merger of Bedford College and Royal Holloway College
Affiliations| ACUAMBAEUAUniversities UK
Website| www.royalholloway.ac.uk [/table] Royal Holloway, University of London (RHUL), formally incorporated as Royal Holloway and Bedford New College, is a publicresearch university and a constituent college of the federal University of London. It has six schools, 21 academic departments and approximately 10,500 undergraduate and postgraduate students from over 100 countries.[5] The campus is located west of Egham, Surrey, 19 miles (31 km) from central London.